No association with the neuregulin 1 haplotype to Japanese schizophrenia SIR-Schizophrenia is a complex genetic disorder and has heritability of around 80%. The pathogenesis of the disease is hypothesized to be neurodevelopmental in nature based on reports of an excess of adverse events during the pre-and perinatal periods, the presence of cognitive and behavioral signs during childhood and adolescence, and the lack of evidence of a neurodegenerative process in most individuals with schizophrenia. 1 To date, studies of the association between schizophrenia and genes coding for neurodevelopmental role has been published. 2 Recently, it has been reported that genetic variants around the gene neuregulin 1 (NRG1) are associated with schizophrenia in an Icelandic sample. 3 The replications of this finding have been reported independently from Scottish population 4 and Caucasians born in UK and Ireland. 5 The at-risk haplotype was found to be over-represented in schizophrenics compared to controls.
Here, we attempt to perform a replication of these results in our collection of Japanese schizophrenic patients and controls. Subjects consisted of 607 patients with schizophrenia and 515 controls. All subjects were unrelated Japanese. Most patients (93%) had more than 1-year duration of illness and 77% patients had history of hospitalization. Consensus diagnosis according to DSM-IV was made. After description of the study, written informed consent was obtained from each subject. This study was approved by the Fujita Health University and the National Center of Neurology and Psychiatry Hospital Ethics Committees. SNP8NRG221132, SNP8NRG221533, SNP8NRG24 3177, and SNP8NRG433E1006 were genotyped using primer extension method by dHPLC. SNP8NRG24 1930 was genotyped using PCR-RFLP method. The microsatellites 478B14-848 and 420M9-1395 were genotyped following analysis on an ABI3100 capillary sequencer. Allele 0 for markers 478B14-848 and 420M9-1395 refers to PCR-product sizes of 219 and 274 bp, respectively.
Deviation from the genotype counts predicted by Hardy-Weinberg equilibrium expectations was tested using an exact test. D, D 0 , and D 2 for pair-wise linkage disequilibrium (LD) were calculated. Estimation of the haplotype frequencies was performed by the expectation-maximization algorithm. Test for single-marker allelic association was performed by w 2 analysis. Test for haplotypic association was performed using the software SAS/Genetics (Release 8.2 TS2M0, SAS Institute Japan) with a permutation test to obtain the empirical significance. 6 We genotyped the five SNPs (SNP8NRG221132, SNP8NRG221533, SNP8NRG241930, SNP8NRG2431 77, SNP8NRG433E1006) and two microsatellite markers (478B14-848, 420M9-1395) that constitute the core haplotype in 607 Japanese patients and 515 Japanese control individuals ( Table 1 ). The genotypic distribution of each locus was not significantly different from the distribution expected according to Hardy-Weinberg equilibrium in this ethnic population. We found no association between each marker and schizophrenia, including the C allele of SNP8NRG221533 (P¼0.42) that was significantly in excess in both Icelandic 3 and Scottish 4 schizophrenia (P¼0.0028 and 0.000064, respectively). The estimated frequency of the core at-risk haplotype, which was enriched in the Scottish and Icelandic patients (10.2%, 14.4%) than in control individuals (5.9%, 7.6%) by Stefansson et al, had no difference between Japanese patients (4.5%) and Japanese controls (4.3%). The estimated Odds Ratio was 1.13 and the 95% confidence interval was (0.60-2.11). In order to be consistent with the literature by Williams and his colleagues, we performed threemarker 'at-risk' haplotype analysis with and without a family history of schizophrenia. However, there are no significant differences among each patent group and control.
Our results do not confirm an involvement of the NRG1 in conferring susceptibility to schizophrenia. One possible explanation for this result could stem from the clinical heterogeneity of schizophrenia. Although the disease is discussed as if it is a single disease, it probably comprises a group of disorders with heterogeneous etiologies. Indeed, the original study was based on individuals taken from large multiply affected families from Iceland. 3 Subsequently, Williams et al 5 discussed sample stratification in which the genetic component might be different in their samples. Further investigations are needed by taking the effect of genetic load into consideration.
Another explanation is that population stratification may exist, since the initial findings started from linkage studies that point out initial evidence for schizophrenia to 8p22-21, where NRG1 is located. 3 In contrast, from Japanese linkage study, no loci on chromosome 8 fulfiled the criteria for significant or suggestive evidence for linkage. 7 According to the common disease/common variants (CD/CV) hypothesis, if the at-risk haplotype is linked to real susceptibility variants, haplotype association test should detect the linkage disequilibrium to the disease variants in different ethnic populations. 8 However, the sample size was not enough such that the power of analysis was reached at 0.18 (when a¼0.05). Additional studies of NRG1 to evaluate across larger numbers of individuals and other ethnic populations should be needed to confirm the hypothesis.
However, it is unclear that single common variants will be the only relevant variants. 9 It is possible that the risk for some common diseases is due to a very large number of loci, with each having a low frequency of disease-predisposing alleles. Allelic heterogeneity may also be contributing to the association of the NRG1 locus with schizophrenia. 10 In the study, we did not search for genetic variants at NRG1 locus in our Japanese samples. Much greater depth of DNA resequencing should be conducted to confirm that unknown rare variants in linkage disequibrium might be a real disease gene. 
